Neuroplasticity-Driven Recovery

MyndMove FES and NMES therapy supports recovery by not only improving movement but also preventing muscle atrophy, reducing spasms, increasing circulation, and re-educating muscles. MyndMove™ caters to a wide range of patients, from those with hemiplegia post-stroke to individuals with C3-T1 SCI. Please refer to the indications for use in Canada and the United States.

By stimulating neural pathways through both afferent (muscle-to-brain) and efferent (brain-to-muscle) signals, MyndMove™ therapy promotes neuroplasticity. Over time, this helps patients regain lasting voluntary motor control in paralyzed limbs, improving both sensory and motor functions.

Unlike some therapies, MyndMove™ leverages neuroplasticity by retraining the brain’s pathways through targeted electrical stimulation. Over time, patients experience lasting voluntary control of paralyzed limbs, making it a comprehensive long-term solution for improving motor function.

By combining cutting-edge technology, therapist expertise, and patient participation, MyndMove™ offers a powerful tool for restoring motor control in individuals with significant impairments.